Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021, 165(3):283-290 | DOI: 10.5507/bp.2020.014

Long-term trends in the incidence, treatment, hospital fatality and subsequent mortality from acute myocardial infarction in the Czech Republic

Jan Bruthansa, b, Otto Mayerb, Jiri Jarkovskyc, Miroslav Zvolskyd, Jan Bruthans jre
a Centre for Cardiovascular Prevention, 1st Faculty of Medicine, Charles University in Prague and Thomayer Hospital, Prague, Czech Republic
b 2nd Department of Medicine, Faculty of Medicine Pilsen, Charles University and Faculty Hospital, Pilsen, Pilsen, Czech Republic
c Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
d Institute of Medical Information and Statistics of the Czech Republic, Prague, Czech Republic
e Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic.

Aims: Studies on the incidence, acute and subsequent mortality from myocardial infarction are limited mostly to selected clinical cohorts and populations and cover relatively short periods. Our aim was to describe and analyse long-term trends on a national scale.

Methods: Acute myocardial infarction (AMI) was defined by the International Classification of Diseases (ICD)10; codes I21 and I22. Our natiowide 1994-2016 data on AMI mortality were obtained from the official mortality statistics (Czech Bureau of Statistics), data on morbidity (hospitalizations) from the National Register of Hospitalizations (Institute for Health Information and Statistics). For further analyses, data from the Czech EUROASPIRE I-V and Czech IMPACT studies were used.

Results: Over the 1994-2016 period the total number of AMI cases per year decreased from 34,084 to 19,015, that of patients hospitalized for AMI from 22,373 to 15,419, the total number of deaths due to AMI from 14,834 to 4,673, in those treated because of AMI from 3,794 to 1,137, and hospital fatality in patients treated for AMI decreased from 17% to 7.5%. Over the years 1997-2016, the one-year all-cause mortality rate after AMI declined from 25.1 to 17.9%, cardiovascular (CV) mortality from 22.3 to 14.2%, five-year all-cause mortality from 41.7 to 34%, and CV mortality from 34.1 to 23.6%.

Conclusion: The Czech Republic has witnessed a pronounced decrease in AMI incidence and fatality and, consequently, long-term mortality. The decreasing incidence and improving course of AMI are due to progress in primary prevention, in acute coronary care and interventional cardiology, and in secondary coronary heart disease (CHD) prevention.

Keywords: acute myocardial infarction, AMI incidence and fatality trends, post-AMI mortality trends, AMI intervention and treatmen, primary and secondary prevention of AMI

Received: January 6, 2020; Revised: March 12, 2020; Accepted: March 16, 2020; Prepublished online: April 6, 2020; Published: September 20, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bruthans, J., Mayer, O., Jarkovsky, J., Zvolsky, M., & Bruthans, J. (2021). Long-term trends in the incidence, treatment, hospital fatality and subsequent mortality from acute myocardial infarction in the Czech Republic. Biomedical papers165(3), 283-290. doi: 10.5507/bp.2020.014
Download citation

References

  1. Bruthans J. Kardiovaskulární onemocnění v České republice v letech 1965-2014 a faktory, které je ovlivňovaly. (Cardiovascular diseases in the Czech Republic 1965-2014 and influencing factors). Praha: Gasset; 2017.
  2. Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, James S, Kellerth T, Lindahl B, Ravn-Fischer A, Rydberg E, Yndigegn T, Jernberg T. Improvedoutcomes in patientswith ST-elevationmyocardialinfarctionduringthe last 20 years are related to implementationofevidence-basedtreatments: experiences fromthe SWEDEHEART registry 1995-2014. EurHeart J 2017;38:3056-65. Go to original source... Go to PubMed...
  3. Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT. 25 years trends in first hospitalization for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012;344:e356. Go to original source... Go to PubMed...
  4. Degano IR, Salomaa V, Veronesi G, Ferrieres J, Kirchberger I, Laks T, Havulinna AS, Ruidavets JB, Ferrario MM, Meisinger C, Elosua R, Marrugat J. Acute Myocardial Infarction Trends in Europe Study Investigators. Twenty-five-years trends in myocardial infarction attack and mortality rates, and case fatality, in six European populations. Heart 2015;101:1413-21. Go to original source... Go to PubMed...
  5. Gerber Y, Weston SA, Jiang R, Roger VL. The changing epidemiology of myocardial infarction in Olmsted county, Minnesota, 1995-2012: Trends in myocardial infarction incidence and recurrence. Am J Med 2015;128:144-51. Go to original source... Go to PubMed...
  6. Nauta ST, Deckers JW, Akkerhuis KM, van Dornburg RT. Short- and long- term mortality after myocardial infarction in patients with and without diabetes. Diabetes Care 2012;35:2043-7. Go to original source... Go to PubMed...
  7. Bata IR, Gregor RD, Wolf HK, Brownell B. Trends in five-year survival of patients discharged after acute myocardial infarction. Can J Cardiol 2006;22:399-404. Go to original source... Go to PubMed...
  8. Smolina K, Wrigh FL, Rayner M, Goldacre MJ. Longterm survival and recurrence after acute myocardial infarction in England, 2004-2010. Circulation: Cardiovascular Quality and Outcomes 2012;5:532-40. Go to original source... Go to PubMed...
  9. Gierlotka M, Zdrojewski T, Wojtyniak B, Polonski L, Stokwiszewski J, Gasior M, Kozerkiewicz A, Kalarus Z, Wierucki L, Chlebus K, Zembala M, Wisocki M, Opolski G. Incidence, treatment, in-hospital and one-year outcomes of acute myocardial infarction in Poland in 2009-2012 - nationwide diabase AMI-PL. Kardiol Pol 2015;73(3):142-58. doi:10.5603/KP.a2014.0213. Go to original source... Go to PubMed...
  10. Sulo G, Igland J, Vollset SE, Ebbing M, Egeland GM, Ariansen I, Tell GS. Trends in incident acute myocardial infarction in Norway: An updated analysis to 2014 using national data from the CVDNOR project. Eur J Prev Cardiol 2018;25:1031-9. Go to original source... Go to PubMed...
  11. Grey C, Jackson R, Wells S, Wu B, Poppe K, White H, Chan WC, Kerr AJ. First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015. Heart 2018;104(1):51-7. doi: 10.1136/heartjnl-2017-311613 Go to original source... Go to PubMed...
  12. Freisinger E, Fuerstenberg T, Malyar NM, Wellman J, Keil U, Breithardt G, Reinecke H. German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life. Eur Heart J 2014;35:979-88. Go to original source... Go to PubMed...
  13. Yeh RW, Sidney S, Chandra M, Sorel M, Selvy JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362:2155-65. Go to original source... Go to PubMed...
  14. Koopman C, Bots ML, van Oeffelen AA, van Dis I, Verschuren WM, Engelfriet PM, Capewell S, Vartjes I. Population trends and inequalities in incidence and short term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol 2013;168:993-8. Go to original source... Go to PubMed...
  15. Bernatová M. Hospitalizovaní a zemřelí na infarkt myokardu v ČR v letech 1986-2000. Aktuální informace ÚZIS ČR č. 20, 2002. (In Czech)
  16. Bernatová M. Hospitalizovaní a zemřelí na infarkt myokardu v ČR v letech 2001-2002. Aktuální informace ÚZIS ČR č. 13, 2004. (In Czech)
  17. Zvolský M. Nemocnost a úmrtnost na ischemické nemoci srdeční v ČR v letech 2003-2010, aktualizace. Aktuální informace ÚZIS ČR č. 24, 2012. (In Czech)
  18. Thygesen K, Alpert JF, Jaffe AS, Simoons ML,Chaitman BR. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67. Go to original source... Go to PubMed...
  19. Mayer O, Bruthans J, Rychecká M. Změny úrovně sekundární prevence ischemické choroby srdeční mezi lety 1995 a 2017. Porovnání studií EUROASPIRE I, II, III, IV a V u českých pacientů. (The changes in secondary CHD prevention between 1995 and 2017 in the Czech patients) Vnitř Lék 2018;64:1190-9. (In Czech)
  20. Bruthans J, Cífková R, Lánská V, O´Flaherty M, Critchley JA, Holub J, Jansky P, Zvárová J, Capewell S. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007. Eur J Prev Cardiol 2012;21:829-39. Go to original source... Go to PubMed...
  21. Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, Khalife K, Goldstein P, Cattan S, Vaur L, Cambou JP, FerriereJ, Danchin N. Association of changes of clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012;308:998-1006. Go to original source... Go to PubMed...
  22. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, López-Sendón J, Goodman SG, Quill A, Fox KA. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-17. Go to original source... Go to PubMed...
  23. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:3232-45. Go to original source... Go to PubMed...
  24. Cífková R, Škodová Z, Bruthans J, Adámková V, Jozífová M, Galovcová M, Wohlfart P, Krajčoviechová A, Poledne R, Stávek P, Lánská V. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Atherosclerosis 2010;211:676-81. Go to original source... Go to PubMed...
  25. Cokkinos DV, Belogianneas Ch. Left ventricular remodelling: a problem in search of solutions. European Cardiology Review 2016;11(1): 29-35. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.